Amneal Pharmaceuticals (AMRX) Tops Q2 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. ABBV
5. CL
6. MRVL
7. LYB
8. TFII
9. NVT
10. SPY

Go back to Amneal Pharmaceuticals (AMRX) Tops Q2 EPS by 6c

Amneal Reports Second Quarter 2021 Financial Results

August 9, 2021 6:00 AM EDT

Q2 2021 Net Revenue of $535 million; GAAP Net Income of $15 million; Diluted Income per Share of $0.10
Adjusted EBITDA (1) of $151 million; Adjusted Diluted EPS (1) of $0.25
Maintaining 2021 Full Year Financial Outlook

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the Company) announced its results today for the second quarter ended June 30, 2021.

Our strong second quarter results reflect the durability and diversity of our business. At a time when drug prices are rising and more people are seeking affordable health care solutions, we... More